Sora Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
- Paid Up Capital ₹ 2.00 M
- Company Age 3 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.00 M
- Revenue Growth 135.85%
- Profit Growth 144.30%
- Ebitda 70.31%
- Net Worth 29.91%
- Total Assets 46.35%
About Sora Diagnostics
Sora Diagnostics Private Limited (SDPL) is a Private Limited Indian Non-Government Company incorporated in India on 08 April 2021 (Three years and ten months 18 days old ). Its registered office is in Chandigarh, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 2.00 M.
The company currently has active open charges totaling ₹4.00 M.
Shamma Mahajan and Surinder Mahajan serve as directors at the Company.
Company Details
- Location
Chandigarh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U33119CH2021PTC043616
- Company No.
043616
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Apr 2021
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Who are the key members and board of directors at Sora Diagnostics?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shamma Mahajan  | Director | 08-Apr-2021 | Current |
| Surinder Mahajan | Director | 08-Apr-2021 | Current |
Financial Performance of Sora Diagnostics.
Sora Diagnostics Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 135.85% increase. The company also saw a substantial improvement in profitability, with a 144.3% increase in profit. The company's net worth Soared by an impressive increase of 29.91%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sora Diagnostics?
Unlock access to Sora Diagnostics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹4.00 M
₹0
Charges Breakdown by Lending Institutions
- Canara Bank : 0.40 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Aug 2024 | Canara Bank | ₹4.00 M | Open |
How Many Employees Work at Sora Diagnostics?
Sora Diagnostics has a workforce of 0 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sora Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sora Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
